malondialdehyde has been researched along with Familial Combined Hyperlipidemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ascaso, JF; Carmena, R; Chaves, FJ; Ivorra, C; Martinez-Hervas, S; Pallardo, FV; Priego, A; Real, JT; Redon, J; ViƱa, JR | 1 |
Blesa, S; Carmena, R; Chaves, FJ; Gonzalez-Albert, V; Mansego, ML; Martinez, F; Martinez-Hervas, S; Real, JT; Redon, J; Saez, GT | 1 |
Bujo, H; Itou, N; Saito, Y; Shibasaki, M; Taira, K; Takahashi, K; Yamazaki, K | 1 |
3 other study(ies) available for malondialdehyde and Familial Combined Hyperlipidemia
Article | Year |
---|---|
Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia.
Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Endothelium, Vascular; Female; Free Radicals; Humans; Hyperlipidemia, Familial Combined; Inflammation; Insulin Resistance; Interleukin-6; Lipid Peroxidation; Lipids; Logistic Models; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; NF-kappa B; Oxidative Stress; Xanthine Oxidase | 2010 |
Different impacts of cardiovascular risk factors on oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Cardiovascular Diseases; Catalase; Deoxyguanosine; Female; Gene Expression Profiling; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Synthase; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertension; Male; Malondialdehyde; Middle Aged; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Risk Factors; Superoxide Dismutase | 2011 |
Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipidemia, Familial Combined; Lipase; Lipoproteins, LDL; Liver; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Polymorphism, Genetic | 2004 |